Professor XYZ received his Ph.D. from Olin Business School, Washington University in St Louis. His primary research interests are in the areas of Corporate finance. Specifically, he works on issues related to Financial Intermediation, Managerial compensation, Politics and Finance, Corporate Investments and Corporate Governance. His work has been accepted at various academic conferences including those hosted by the American Finance Association and European Finance Association. Professor Alok has also worked on a consulting project for CitiMortgage which involved identifying the causes of strategic defaults by borrowers. Prior to his Ph.D., he graduated from the ManipalUniversity in Computer Science and Engineering amongst the top of the graduating class.
- Ph D (Public Policy and Management), Heinz College,Carnegie Mellon University
- M.Phil (Public Policy and Management), Heinz College,Carnegie Mellon University
- MBA ((PGDCM with Major in Economics)), IIM Calcutta
- B.Tech (Civil Engineering), IIT Roorkee
Bhaskarabhatla A..,Chatterjee, Chirantan. (forthcoming) "Competition Issues in Indian Pharmaceutical Markets. Forthcoming", Journal of Antitrust Enforcement, Oxford University Press
Chatterjee, Chirantan.,Shreekanth Mahendiran and)..,Neil Shah. (2018) "Dis (connecting) People: 2016 Indian Demonetization and Mobile Phone Markets", ISB Insights
Chatterjee, Chirantan. (2017) "Analyzing the Lazy Mother Argument Inspired by the Maggi Controversy", Economic & Political Weekly
, 52(28), 49
Chatterjee, Chirantan.,Bhaskarabhatla A.. (2017) "The role of physicians in prescribing irrational fixed-dose combination medicines in India", Social Science & Medicine
, 174, 179-187
Bhaskarabhatla A.,Chatterjee, Chirantan.,Anurag P..,Pennings E.. (2017) "Mitigating regulatory impact: the case of partial price controls on metformin in India", Health Policy and Planning
, 32 (2), 194-204
Chatterjee, Chirantan.,Joshi R..,Sood N..,Boregowda P.. (2017) "Government health insurance and spatial peer effects: New evidence from India", Social Science & Medicine
, 196, 131-141
Chakraborty P.,Chatterjee, Chirantan. (2017) "Does Environmental Regulation Indirectly Induce Upstream Innovation? New Evidence from India", Research Policy
, 46(5), 939-955
Bhaskarabhatla A..,Chatterjee, Chirantan. (2017) "Whither competition law in Indian pharmaceutical markets? Evidence from arbitration data of CCI and COMPAT", Journal of Antitrust Enforcement
Pingali V..,Chaudhuri M.K..,Malik P..,Tamara R..,Kakkar A..,Chatterjee, Chirantan.,Mondal S..,Sokol D. Daniel. (2016) "Competition Law in India: Perspectives", Vikalpa
, 41: 168-193
Branstetter L..,Chatterjee, Chirantan.,Higgins M. J.. (2016) "Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry", The RAND Journal of Economics
, 47(4), 857-890. NBER Working Paper 17188
Chatterjee, Chirantan.,Pingali V.. (2015) "Balancing Affordability and Availability in a Drug Patent Regime", Economic & Political Weekly
, 50(41), 20-23
Chatterjee, Chirantan.,Kubo K..,Pingali V. (2015) "The consumer welfare implications of governmental policies and firm strategy in markets for medicines", Journal of Health Economics
, 44, 255-273
Chatterjee, Chirantan.,Kubo K..,Pingali V.. (2013) "Crocin or paracetamol – What should the doctor prescribe", Economic & Political Weekly
, Vol - XLVIII, No. 41
Chatterjee, Chirantan. (2009) "The historical evolution of post-TRIPs modern Indian pharmaceuticals. Prescribing cultures and pharmaceutical policy", Stanford University, The Brookings Press
Chatterjee, Chirantan.,Mahendiran S.. "The emerging market for biological drugs in India", India & Innovation, Oxford University Press (India) & University of Pennsylvania
Chatterjee, Chirantan.,Reechal Vardhan. (2017) "Roposo.com: Share Your Style: Entrepreneurial Pivoting & Strategic Thinking in Indian Fashion Social Networking", Harvard Business Publishing Case Study
Chatterjee, Chirantan.,Swapnika Ramu. (2017) "edX Mini-MOOC-Cases on Strand Life Sciences, HCG Oncology, UE Lifesciences & Portea Medical",
Branstetter L.,Chatterjee, Chirantan.,Higgins M.J.. "Starving (or fattening) the golden goose? Generic entry and the incentives for early-stage pharmaceutical innovation"
Adbi A..,Bhaskarabhatla A.S..,Chatterjee, Chirantan. "The Market Impact of Stakeholder Entrepreneur Entry: Evidence from Indian Pharmaceuticals"
Bhaskarabhatla A..,Chatterjee, Chirantan.,Anurag P..,Pennings E.. "Effort Diversion as a Firm Strategy to Respond to Partial Price Cap Regulation"
Adbi A..,Chatterjee, Chirantan.,Kinias Z..,Singh J.. "Women’s Disempowerment and the Market for Skin Whitening Products: Experimental Evidence from India"
Adbi A.,Chatterjee, Chirantan.,Drev M..,Mishra A.. "When the Big One Came: A Natural Experiment on Demand Shocks and Market Structure in India’s Influenza Vaccine Markets"